<DOC>
	<DOC>NCT00234871</DOC>
	<brief_summary>The primary objective of this study is to determine if trandolapril/verapamil (Tarka速) is superior to amlodipine/benazepril (Lotrel速) in reduction of albuminuria in hypertensive subjects with Type 2 diabetes mellitus (DM) and diabetic nephropathy</brief_summary>
	<brief_title>Tarka速 vs. Lotrel速 in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Trandolapril</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>Diabetes Hypertension Albuminuria Type 1 DM. Subject has severe hepatic dysfunction at Screening as determined by liver function tests: Bilirubin &gt; 2.0 mg/dL. ALT and/or AST &gt; 3 times the upper limit of normal. Subject has poorly controlled diabetes, based on HbA1c &gt; 10% at Screening. Subject has nondiabetic renal disease. Subject has a hypersensitivity to ACE inhibitor, CCB, torsemide or sulfonylureas.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Proteinuria</keyword>
	<keyword>Tarka</keyword>
	<keyword>Lotrel</keyword>
</DOC>